A Comprehensive Assessment Using COPD Assessment Test Scoring and Modified Medical Research Council Dyspnea Scoring is Necessary for Personalized Therapy for COPD Patients

Ohno T, Wada S, Hanada S, Sawaguchi H, Muraki M, Tohda Y . Efficacy of indacaterol on quality of life and pulmonary function in patients with COPD and inhaler device preferences. Int J Chron Obstruct Pulmon Dis. 2014; 9:107-14. PMC: 3904808. DOI: 10.2147/COPD.S56777. View

Casanova C, Marin J, Martinez-Gonzalez C, de Lucas-Ramos P, Mir-Viladrich I, Cosio B . Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD. Chest. 2015; 148(1):159-168. DOI: 10.1378/chest.14-2449. View

Rhee C, Kim J, Hwang Y, Lee J, Jung K, Lee M . Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2015; 10:1623-31. PMC: 4541543. DOI: 10.2147/COPD.S87147. View

Price D, Baker C, Zou K, Higgins V, Bailey J, Pike J . Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification. Int J Chron Obstruct Pulmon Dis. 2014; 9:551-61. PMC: 4043424. DOI: 10.2147/COPD.S62104. View